31.12.2012 Views

Bulletin 2012/02 - European Patent Office

Bulletin 2012/02 - European Patent Office

Bulletin 2012/02 - European Patent Office

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

(A61K) I.1(1)<br />

• KINASE PROTEIN BINDING INHIBITORS<br />

• INHIBITEURS DE LIAISON DE PROTÉINE<br />

KINASE<br />

(71) University of Florida Research Foundation,<br />

Inc., P.O. Box 11550, Gainesville, Florida<br />

32611-5500, US<br />

(72) GOLUBOVSKAYA, Vita, Orchard Park, NY<br />

14127, US<br />

OSTROV, David, A., Gainesville, FL 32607,<br />

US<br />

CANCE, William, G., Buffalo, NY 14263, US<br />

(74) Maschio, Antonio, Edwards Wildman Innovations<br />

LLP 10 Carlton Crescent, Southampton<br />

SO15 2EZ, GB<br />

A61K 31/397 → (51) C07D 405/10<br />

A61K 31/40 → (51) A61K 31/395<br />

A61K 31/40 → (51) A61K 31/4035<br />

(51) A61K 31/4015 (11) 2 403 495 A1*<br />

A61K 31/4415 A61P 1/16<br />

(25) It (26) En<br />

(21) 10712519.7 (22) 04.03.2010<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(86) IB 2010/050930 04.03.2010<br />

(87) WO 2010/100619 2010/36 10.09.2010<br />

(30) 06.03.2009 IT MI20090333<br />

(54) • METADOXIN ZUR VERWENDUNG ALS<br />

MITTEL ZUR UNTERDRÜCKUNG VON<br />

LEBERFIBROSE<br />

• METADOXINE FOR USE AS INHIBITOR OF<br />

HEPATIC FIBROSIS<br />

• MÉTADOXINE DESTINÉE À ÊTRE UTILISÉE<br />

EN TANT QU'INHIBITEUR D'UNE FIBROSE<br />

HÉPATIQUE<br />

(71) Laboratori Baldacci SPA, Via San Michele<br />

degli Scalzi 73, 56100 Pisa, IT<br />

(72) BALDACCI, Massimo, I-56125 Pisa, IT<br />

(74) Bartorelli, Luisa, et al, Dragotti & Associati<br />

Via Marina, 6, IT-<strong>2012</strong>1 Milano, IT<br />

A61K 31/4<strong>02</strong>5 → (51) C07D 405/10<br />

(51) A61K 31/4035 (11) 2 403 496 A1*<br />

A61K 31/40 A61P 31/12<br />

A61P 35/00<br />

(25) En (26) En<br />

(21) 10748252.3 (22) <strong>02</strong>.03.2010<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(86) CA 2010/00<strong>02</strong>81 <strong>02</strong>.03.2010<br />

(87) WO 2010/099600 2010/36 10.09.2010<br />

(30) <strong>02</strong>.03.2009 US 156560 P<br />

(54) • VERBINDUNGEN UND VERFAHREN ZUR<br />

BEHANDLUNG VON KREBS UND VIRU-<br />

SINFEKTIONEN<br />

• COMPOUNDS AND METHODS FOR<br />

TREATING CANCER AND VIRAL INFEC-<br />

TIONS<br />

• COMPOSÉS ET PROCÉDÉS POUR LE<br />

TRAITEMENT D'UN CANCER ET D'INFEC-<br />

TIONS VIRALES<br />

(71) Goff Hill Limited, Worthing Corporate Center<br />

Worthing, Christ Church 15008, BB<br />

(72) TUCKER, William G., Charlottetown, Prince<br />

Edward Island C1A 3S4, CA<br />

(74) Clyde-Watson, Zöe, D Young & Co LLP 120<br />

Holborn, London EC1N 2DY, GB<br />

A61K 31/4045 → (51) C07D 209/16<br />

(51) A61K 31/41 (11) 2 403 497 A1*<br />

A61K 31/352<br />

A61P 35/00<br />

A61K 31/498<br />

Europäisches <strong>Patent</strong>blatt<br />

<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />

<strong>Bulletin</strong> européen des brevets<br />

(25) En (26) En<br />

(21) 10748321.6 (22) 01.03.2010<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(86) CN 2010/070813 01.03.2010<br />

(87) WO 2010/099731 2010/36 10.09.2010<br />

(30) 01.03.2009 US 156507 P<br />

(54) • VERBINDUNGEN, ZUSAMMENSETZUNGEN<br />

UND VERWENDUNG FÜR ANTIKREBS-<br />

THERAPIE<br />

• COMPOUNDS, COMPOSITIONS AND USE<br />

FOR ANTICANCER THERAPY<br />

• COMPOSÉS, COMPOSITIONS ET UTILI-<br />

SATION POUR UNE THÉRAPIE ANTICAN-<br />

CÉREUSE<br />

(71) Yu, Ming, Xinxing Road 36 Gate 1 Unit 307,<br />

Heping District, Tianjin 300070, CN<br />

(72) Yu, Ming, Heping District, Tianjin 300070,<br />

CN<br />

(74) Jennings, Nigel Robin, Kilburn & Strode LLP<br />

20 Red Lion Street, London WC1R 4PJ, GB<br />

A61K 31/41 → (51) A01N 43/82<br />

A61K 31/41 → (51) C07D 233/54<br />

A61K 31/41 → (51) C07D 405/10<br />

A61K 31/415 → (51) A01N 43/50<br />

A61K 31/4155 → (51) C07D 231/12<br />

(51) A61K 31/416 (11) 2 403 498 A2*<br />

A61K 31/69 A61K 45/06<br />

A61P 7/04 A61P 9/12<br />

(25) En (26) En<br />

(21) 10749399.1 (22) 05.03.2010<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(86) US 2010/<strong>02</strong>6377 05.03.2010<br />

(87) WO 2010/1<strong>02</strong>216 2010/36 10.09.2010<br />

(88) 13.01.2011<br />

(30) 05.03.2009 US 157719 P<br />

(54) • GERINNUNGSVERSTÄRKUNG ODER FIB-<br />

RINOLYSE-REDUZIERUNG<br />

• ENHANCING COAGULATION OR REDU-<br />

CING FIBRINOLYSIS<br />

• AMÉLIORATION DE LA COAGULATION OU<br />

RÉDUCTION D'UNE FIBRINOLYSE<br />

(71) The UAB Research Foundation, 1530 3rd<br />

Avenue South, AB 770G, Birmingham, Alabama<br />

35294, US<br />

(72) NIELSEN, Vance G., Birmingham, Alabama<br />

35243, US<br />

GEORGE, James F., Birmingham, Alabama<br />

35226, US<br />

KIRKLIN, James K., Birmingham, Alabama<br />

35242, US<br />

(74) Leissler-Gerstl, Gabriele, Hoefer & Partner<br />

<strong>Patent</strong>anwälte Pilgersheimer Strasse 20,<br />

81543 München, DE<br />

A61K 31/4188 → (51) C07D 471/04<br />

A61K 31/422 → (51) C07D 405/10<br />

A61K 31/423 → (51) C07D 413/12<br />

A61K 31/4245 → (51) C07D 413/04<br />

A61K 31/428 → (51) A61K 31/47<br />

A61K 31/4355 → (51) C07D 491/04<br />

A61K 31/437 → (51) A61K 9/16<br />

38<br />

Anmeldungen<br />

Applications<br />

Demandes (<strong>02</strong>/<strong>2012</strong>) 11.01.<strong>2012</strong><br />

A61K 31/4375 → (51) C07D 215/48<br />

A61K 31/44 → (51) C07D 213/75<br />

A61K 31/4406 → (51) A61K 31/166<br />

A61K 31/4412 → (51) C07D 401/10<br />

A61K 31/4415 → (51) A61K 31/4015<br />

A61K 31/4427 → (51) A61K 31/47<br />

A61K 31/443 → (51) C07D 401/04<br />

A61K 31/4433 → (51) C07D 401/04<br />

A61K 31/4436 → (51) A61K 31/47<br />

A61K 31/444 → (51) C07D 401/10<br />

A61K 31/4468 → (51) A61K 9/16<br />

A61K 31/45 → (51) C07D 401/04<br />

A61K 31/4523 → (51) C07D 405/10<br />

(51) A61K 31/47 (11) 2 403 499 A2*<br />

A61K 31/4436 A61K 31/4427<br />

A61K 31/428 A61P 35/00<br />

(25) En (26) En<br />

(21) 10749239.9 (22) <strong>02</strong>.03.2010<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(86) US 2010/<strong>02</strong>5984 <strong>02</strong>.03.2010<br />

(87) WO 2010/101964 2010/36 10.09.2010<br />

(88) 13.01.2011<br />

(30) <strong>02</strong>.03.2009 US 156741 P<br />

(54) • VERFAHREN UND ZUSAMMENSETZUN-<br />

GEN ZUR BEHANDLUNG VON KREBS UND<br />

REDUZIERUNG VON WNT-VERMITTELTEN<br />

EFFEKTEN IN EINER ZELLE<br />

• METHODS AND COMPOSITIONS USEFUL<br />

IN TREATING CANCER AND REDUCING<br />

WNT MEDIATED EFFECTS IN A CELL<br />

• MÉTHODES ET COMPOSITIONS UTILES<br />

POUR TRAITER LE CANCER ET RÉDUIRE<br />

LES EFFETS MÉDIÉS PAR WNT DANS UNE<br />

CELLULE<br />

(71) Stemsynergy Therapeutics, Inc, 4300 East<br />

Tradewinds Avenue, Lauderdale by the Sea,<br />

Florida 33308, US<br />

(72) ORTON, Darren, Nashville Tennessee 37221,<br />

US<br />

(74) Harrison Goddard Foote, Belgrave Hall Belgrave<br />

Street, Leeds LS2 8DD, GB<br />

A61K 31/47 → (51) C07D 215/48<br />

A61K 31/47 → (51) C07D 401/14<br />

A61K 31/4709 → (51) C07D 215/48<br />

A61K 31/4709 → (51) C07D 401/04<br />

A61K 31/4741 → (51) C07D 401/04<br />

A61K 31/495 → (51) A01N 43/58<br />

A61K 31/497 → (51) C07D 215/48<br />

A61K 31/497 → (51) C07D 401/10<br />

A61K 31/498 → (51) A61K 31/41<br />

A61K 31/4985 → (51) C07D 487/04<br />

A61K 31/50 → (51) A01N 43/58

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!